Mark P Purdue Selected Research

Messenger RNA (mRNA)

7/2015	Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data.
4/2012	Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer.
3/2012	Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark P Purdue Research Topics

Disease

68	Neoplasms (Cancer) 06/2024 - 10/2005
27	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 06/2006
17	Renal Cell Carcinoma (Grawitz Tumor) 10/2023 - 07/2010
17	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 04/2008
16	Kidney Neoplasms (Kidney Cancer) 01/2022 - 07/2010
12	Multiple Myeloma 04/2020 - 02/2009
11	Urinary Bladder Neoplasms (Bladder Cancer) 01/2024 - 11/2010
10	Inflammation (Inflammations) 01/2020 - 07/2009
8	Obesity 01/2019 - 11/2012
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 03/2007
7	Lung Neoplasms (Lung Cancer) 01/2022 - 02/2007
7	Carcinogenesis 01/2020 - 04/2010
6	Liver Neoplasms (Liver Cancer) 07/2023 - 09/2015
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2005
6	Hypertension (High Blood Pressure) 01/2017 - 08/2011
5	Breast Neoplasms (Breast Cancer) 01/2024 - 04/2008
5	Glioma (Gliomas) 07/2021 - 08/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 07/2010
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023 - 01/2015
4	Lymphoma (Lymphomas) 01/2023 - 10/2004
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 10/2014
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017 - 02/2010
4	Overweight 01/2017 - 07/2010
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2023 - 04/2008
3	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 06/2008
3	Adenoma (Adenomas) 01/2021 - 10/2005
3	Cholangiocarcinoma 01/2020 - 09/2015
3	Chronic Disease (Chronic Diseases) 07/2015 - 08/2011
3	Insulin Resistance 07/2015 - 01/2013
3	Laryngeal Neoplasms (Laryngeal Cancer) 09/2011 - 08/2006
2	Gallbladder Neoplasms (Gallbladder Cancer) 06/2024 - 01/2018
2	Basal Cell Carcinoma (Rodent Ulcer) 01/2024 - 05/2023
2	Triple Negative Breast Neoplasms 01/2024 - 05/2023
2	Adenocarcinoma 10/2023 - 01/2019
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2023 - 06/2013
2	Melanoma (Melanoma, Malignant) 07/2021 - 02/2007
2	Monoclonal Gammopathy of Undetermined Significance 09/2019 - 01/2017
2	Leukemia 01/2019 - 02/2007
2	Hepatocellular Carcinoma (Hepatoma) 12/2015 - 09/2015
2	Infections 04/2015 - 10/2014

Drug/Important Bio-Agent (IBA)

25	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
21	ORALIT (ORS)IBA 07/2023 - 02/2010
17	Vitamin D FDA LinkGeneric 01/2022 - 04/2008
16	hydroxide ionIBA 01/2022 - 04/2008
13	25-hydroxyvitamin DIBA 01/2022 - 06/2008
10	CytokinesIBA 01/2021 - 01/2007
9	Trichloroethylene (Trichloroethene)IBA 10/2021 - 09/2010
8	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 04/2010
7	CarcinogensIBA 05/2024 - 04/2012
6	Coffee FDA Link 06/2024 - 07/2010
6	FluorocarbonsIBA 02/2024 - 01/2021
6	perfluorooctanoic acidIBA 02/2024 - 01/2021
6	SolventsIBA 01/2019 - 02/2011
6	AdiponectinIBA 07/2017 - 11/2012
6	Proteins (Proteins, Gene)FDA Link 04/2015 - 01/2007
5	Hormones (Hormone)IBA 07/2023 - 01/2017
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 10/2013
5	beta Carotene (Betacarotene)FDA Link 01/2015 - 02/2009
5	alpha-Tocopherol FDA Link 01/2015 - 02/2009
5	Mitochondrial DNA (mtDNA)IBA 01/2015 - 01/2012
4	ChemokinesIBA 01/2023 - 01/2017
4	Benzene (Benzole)IBA 10/2019 - 10/2015
4	AntibodiesIBA 01/2018 - 04/2015
4	Calcitriol Receptors (Calcitriol Receptor)IBA 07/2010 - 08/2007
3	TeaIBA 06/2024 - 07/2010
3	Gonadal Steroid Hormones (Sex Hormones)IBA 07/2023 - 01/2020
3	AntigensIBA 10/2019 - 03/2012
3	Insulin (Novolin)FDA Link 01/2019 - 12/2012
3	PesticidesIBA 01/2019 - 06/2006
3	RNA (Ribonucleic Acid)IBA 01/2017 - 04/2010
3	Messenger RNA (mRNA)IBA 07/2015 - 03/2012
3	AdipokinesIBA 07/2013 - 11/2012
3	LeptinIBA 07/2013 - 11/2012
3	Interleukin-10 (Interleukin 10)IBA 06/2013 - 01/2007
2	Macrophage Migration-Inhibitory FactorsIBA 01/2024 - 05/2023
2	AdrenomedullinIBA 01/2024 - 05/2023
2	Interleukin-23 (Interleukin 23)IBA 01/2024 - 05/2023
2	Prothrombin (Factor II)IBA 01/2024 - 05/2023
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2024 - 05/2023
2	perfluorooctaneIBA 10/2023 - 01/2023
2	Estrogen ReceptorsIBA 01/2023 - 07/2021
2	Genetic Markers (Genetic Marker)IBA 01/2023 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2009
2	Vitamin D-Binding ProteinIBA 01/2022 - 03/2015
2	CotinineIBA 01/2021 - 01/2020
2	SmokeIBA 01/2021 - 04/2012
2	Ibuprofen (Motrin)FDA LinkGeneric 01/2021 - 12/2015
2	LipidsIBA 01/2020 - 01/2019
2	CC ChemokinesIBA 01/2019 - 01/2017
2	Tetrachloroethylene (Tetrachloroethene)IBA 01/2019 - 01/2017
2	LigandsIBA 01/2019 - 01/2017
2	Polychlorinated Biphenyls (PCBs)IBA 01/2019 - 10/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 10/2014
2	ResistinIBA 10/2017 - 01/2013
2	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2017 - 11/2012
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017 - 12/2012
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017 - 01/2009
2	MetalsIBA 01/2017 - 02/2011
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2015 - 10/2013

Therapy/Procedure

2	Hysterectomy 01/2014 - 06/2013